XLHealth Advised by Latham & Watkins in its Acquisition by UnitedHealth

Acquisition will close in first half of 2012.

November 23, 2011

XLHealth Corporation, a sponsor of Medicare Advantage health plans with a primary focus on Medicare recipients with special needs, such as those with chronic illness and those also eligible for Medicaid, has announced it will be acquired by UnitedHealthcare. The acquisition is expected to close during the first half of 2012. Working with XLHealth’s Chief Legal Officer, Daniel J. Friedman, Latham & Watkins LLP advised XLHealth in the transaction with a deal team led by New York corporate partner John Giouroukakis and associates Thomas Malone, Melissa Baumgartner, Mark Woods and Emily Rosenblum. Advice was also provided by Washington, D.C. healthcare partner Stuart Kurlander and associate Eric Greig and San Francisco associate Betty Pang; New York tax partner David Raab and associates Jocelyn Noll and Jonathan Stein; New York antitrust partner Bruce Prager and associate Virginia Tent; New York benefits and compensation partner Bradd Williamson and associates Rifka Singer and Hayley Moore; New York intellectual property partner Jeffrey Tochner and associate Gabrielle Russell; and New York environmental counsel David Langer.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.